Dashboard
Manage Tickers

ANNXAnnexon, Inc.

Nasdaq annexonbio.com


$ 4.74 $ -0.08 (-1.66 %)    

Tuesday, 07-May-2024 15:59:46 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 440.32 $ 0.07 (0.02 %)
DIA $ 388.70 $ 0.29 (0.07 %)
SPY $ 517.26 $ 0.57 (0.11 %)
TLT $ 90.79 $ 0.55 (0.61 %)
GLD $ 214.23 $ -0.99 (-0.46 %)
$ 4.73
$ 4.89
$ 0.00 x 0
$ 0.00 x 0
$ 4.71 - $ 4.96
$ 1.57 - $ 8.40
2,334,061
na
357.93M
$ 1.20
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-26-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-07-2023 06-30-2023 10-Q
4 05-08-2023 03-31-2023 10-Q
5 03-06-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-08-2022 06-30-2022 10-Q
8 05-09-2022 03-31-2022 10-Q
9 03-01-2022 12-31-2021 10-K
10 11-09-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-17-2021 03-31-2021 10-Q
13 03-25-2021 12-31-2020 10-K
14 11-16-2020 09-30-2020 10-Q
15 09-08-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

annexon-to-present-data-of-additional-phas3-2-clinical-results-of-anx007-from-archer-trial-in-geographic-atrophy-including-further-analyses-of-visual-acuity-and-photoreceptor-preservation-at-arvo-2024-annual-meeting
Annexon To Present Data Of Additional Phas...
05/01/2024 12:27:42

Additional data from the Phase 2 ARCHER trial demonstrating protection of visual acuity and anatomical structure following ANX0...

cantor-fitzgerald-reiterates-overweight-on-annexon
Cantor Fitzgerald Reiterates Overweight on...
04/24/2024 12:54:56

Cantor Fitzgerald analyst Pete Stavropoulos reiterates Annexon (NASDAQ:ANNX) with a Overweight.

needham-reiterates-buy-on-annexon-maintains-16-price-target
Needham Reiterates Buy on Annexon, Maintai...
04/11/2024 11:17:33

Needham analyst Joseph Stringer reiterates Annexon (NASDAQ:ANNX) with a Buy and maintains $16 price target.

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
04/09/2024 17:35:25

annexon-inc-entered-sales-agreement-relating-to-sale-of-shares-of-common-stock-may-offer-shares-of-common-stock-from-time-to-time-for-100m
Annexon Inc Entered Sales Agreement Relati...
04/05/2024 20:13:40

- SEC Filing

cantor-fitzgerald-reiterates-overweight-on-annexon
Cantor Fitzgerald Reiterates Overweight on...
04/03/2024 13:33:13

Cantor Fitzgerald analyst Pete Stavropoulos reiterates Annexon (NASDAQ:ANNX) with a Overweight.

wells-fargo-maintains-overweight-on-annexon-maintains-12-price-target
Wells Fargo Maintains Overweight on Annexo...
04/01/2024 15:56:38

Wells Fargo analyst Derek Archila maintains Annexon (NASDAQ:ANNX) with a Overweight and maintains $12 price target.

jp-morgan-maintains-overweight-on-annexon-raises-price-target-to-13
JP Morgan Maintains Overweight on Annexon,...
04/01/2024 13:53:42

JP Morgan analyst Anupam Rama maintains Annexon (NASDAQ:ANNX) with a Overweight and raises the price target from $11 to $13.

b-of-a-securities-maintains-buy-on-annexon-raises-price-target-to-10
B of A Securities Maintains Buy on Annexon...
03/28/2024 18:14:53

B of A Securities analyst Tazeen Ahmad maintains Annexon (NASDAQ:ANNX) with a Buy and raises the price target from $7 to $10.

cintas-reports-upbeat-earnings-joins-paysign-noah-holdings-and-other-big-stocks-moving-higher-on-wednesday
Cintas Reports Upbeat Earnings, Joins PayS...
03/27/2024 14:03:27

U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.

hc-wainwright--co-maintains-buy-on-annexon-maintains-30-price-target
HC Wainwright & Co. Maintains Buy on Annex...
03/27/2024 13:03:59

HC Wainwright & Co. analyst Andrew Fein maintains Annexon (NASDAQ:ANNX) with a Buy and maintains $30 price target.

wells-fargo-maintains-overweight-on-annexon-raises-price-target-to-12
Wells Fargo Maintains Overweight on Annexo...
03/27/2024 12:56:18

Wells Fargo analyst Derek Archila maintains Annexon (NASDAQ:ANNX) with a Overweight and raises the price target from $11 to ...

needham-reiterates-buy-on-annexon-maintains-16-price-target
Needham Reiterates Buy on Annexon, Maintai...
03/27/2024 10:53:30

Needham analyst Joseph Stringer reiterates Annexon (NASDAQ:ANNX) with a Buy and maintains $16 price target.

annexon-filed-for-mixed-shelf-offering-of-up-to-400m
Annexon Filed For Mixed Shelf Offering Of ...
03/26/2024 21:08:59

annexon-q4-eps-036-beats-048-estimate
Annexon Q4 EPS $(0.36) Beats $(0.48) Estimate
03/26/2024 20:30:57

Annexon (NASDAQ:ANNX) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.48) by 25...

why-cutera-shares-are-trading-lower-by-over-26-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Cutera Shares Are Trading Lower By Ove...
03/22/2024 18:39:16

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected four...

worthington-steel-posts-upbeat-results-joins-summit-midstream-partners-fedex-and-other-big-stocks-moving-higher-on-friday
Worthington Steel Posts Upbeat Results, Jo...
03/22/2024 14:08:47

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
03/14/2024 13:06:15

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
03/13/2024 17:31:16

why-clover-health-investments-shares-are-trading-higher-by-11-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Clover Health Investments Shares Are T...
03/13/2024 17:18:56

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported b...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION